MedPath

A Study To Compare The Block Characteristics Of A Drug Named Ropivacaine 0.75% Heavy And 0.5% Bupivacaine Heavy For Spinal Anaesthesia In Infraumbillical Surgeries

Phase 4
Conditions
Health Condition 1: 8- Other Procedures
Registration Number
CTRI/2023/11/059573
Lead Sponsor
Dr R Jagadish Raj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

2.Patient willing to give informed consent

3.ASA grade 1 and 2

4.Patients undergoing infraumbilical surgeries under spinal anaesthesia.

Exclusion Criteria

1.Patients refusing to give informed consent

2.Patients undergoing emergency surgeries

3.Patients with history of allergy to the study drugs

4.Pregnant women

5.Patients ASA grade 3,4,5

6.Patients under 18 years and over 60 years of age.

7.Infection at the site of injection

8.Sepsis

9.Spinal deformities

10.Severe hypovolemia

11.Coagulopathies

12.Raised intracranial tension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effects of hyperbaric ropivacaine 0.75% with hyperbaric bupivacaine 0.5% on onset, duration, time to maximum sensory and motor block.maximum level of sensory block, time to 2 segment regression of sensory blockTimepoint: baseline, every minute upto 10 minutes, every 10 minutes upto end of surgery
Secondary Outcome Measures
NameTimeMethod
To compare the effects of the 2 drugs on heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, saturation of oxygen & the incidence of adverse effects if any.Timepoint: baseline, every minute upto 10 minutes, every 10 minutes upto end of surgery
© Copyright 2025. All Rights Reserved by MedPath